Advertisement

Drug Transport Across the Blood-Brain Barrier

  • G. Fricker
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 37)

Abstract

Case numbers of neurodegenerative disorders, such as Alzheimer’s disease, Morbus Parkinson, epilepsy, brain tumours or human immunodeficiency virus (HIV)-related encephalopathy, are continuously increasing, thereby causing enormous costs to the public economy. For example, following the World Health Report, more than 12 million people are suffering from Alzheimer’s disease worldwide. With more than 4 million patients at an annual expense of over US $50 billion, the disease has currently become the third largest medical problem in the United States (Friden 1996).

Keywords

Brain Endothelial Cell Brain Capillary Brain Capillary Endothelial Cell Porcine Brain Brain Microvessel Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arthur PE, Shivers RR, Bowman PD (1987) Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model. Brain Res 433: 155–159PubMedGoogle Scholar
  2. Bornstein MB (1958) Reconstituted rat-tail collagen used as substrate for tissue cultures on coverslips in maximow slides and roller tubes. Lab Invest 7: 134–137PubMedGoogle Scholar
  3. Bradbury MWB (1993) The blood brain barrier. Exp Physiol 78:453–462 Brightman MW, Reese TS (1969) Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40: 648–677Google Scholar
  4. Cerletti A, Drewe J, Fricker G, Eberle A, Huwyler J (2000) Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Targ 8: 435–447CrossRefGoogle Scholar
  5. Choo EF, Leake B, Wandel C, Imamura H, Wood AJ, Wilkinson GR., Kim RB (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos 28: 655–660PubMedGoogle Scholar
  6. Crone C, Olesan SP (1982) Electrical resistance of brain microvascular endothelium. Brain Res 241: 49–55PubMedCrossRefGoogle Scholar
  7. Drewe J, Gutmann H, Fricker G, Török M, Beglinger C, Huwyler J (1999) HIV protease inhibitor ritonavir: A more potent inhibitor of p-glycopotein than the cyclosporine analogue SDZ PSC-833. Biochem Pharmacol 57: 1147–1152PubMedCrossRefGoogle Scholar
  8. Ehrlich P (1885) Das Sauerstoffbedürfniss des Organismus. In: Hirschwald A (ed) Eine farbenanalytische Studie, BerlinGoogle Scholar
  9. Friden PM (1996) Utilisation of an endogeneous cellular transport system for the delivery of therapeutics across the across the blood-brain barrier. J Contr Rel 46: 117–128CrossRefGoogle Scholar
  10. Golden PL, Pardridge WM (1999) P-Glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Res 819: 143–146PubMedCrossRefGoogle Scholar
  11. Goldmann EE (1913) Vitalfärbung am Zentralnervensystem. Berlin Goldstein GW, Betz AL (1986) The blood brain barrier. Sci Am 255: 70–79Google Scholar
  12. Goldstein GW, Wolinsky JS, Csejtey J, Diamond I (1975) Isolation of metabolically active capillaries from rat brain. J Neurochem 25: 715–717PubMedCrossRefGoogle Scholar
  13. Greenwood J, Begley DJ, Segal MB (1995) New concepts of a blood-brain barrier. Plenum Press, New York and LondonGoogle Scholar
  14. Huwyler J, Wu D, Pardridge WM (1996) Brain drug delivery of small mole- cules using immunoliposomes. Proc Natl Acad Sci USA 93: 14164–14169PubMedCrossRefGoogle Scholar
  15. Huwyler J, Yang J, Pardridge WM (1997) Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat. J Pharmacol Exp Ther 282: 1541–1546PubMedGoogle Scholar
  16. Huwyler J, Froidevaux S, Roux F, Eberle AN (1999) Characterization of transferrin receptor in an immortalized cell line of rat brain endothelial cells, RBE4. J Recept Signal Transduct Res 19: 729–739PubMedCrossRefGoogle Scholar
  17. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101: 289–294PubMedCrossRefGoogle Scholar
  18. Maher F, Vannucci SJ, Simpson IA (1994) Glucose transporter proteins in brain. FASEB J 8: 1003–1011PubMedGoogle Scholar
  19. Miller DS, Nobmann S, Gutmann H, Török M, Drewe J, Fricker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharm 58: 1357–1363Google Scholar
  20. Mrsulja BB, Mrsulja BJ, Fujimoto T, Klatzo I, Spatz M (1976) Isolation of brain capillaries: a simplified technique. Brain Res 110: 361–365PubMedCrossRefGoogle Scholar
  21. Nobmann S, Bauer B, Fricker G (2001) Ivermectin excretion by isolated functionally intact brain endothelial capillaries. Brit J Pharm 132: 722–728CrossRefGoogle Scholar
  22. Pardridge WM (1998) Blood brain barrier carrier-mediated transport and meta-bolism of amino acids. Neurochem Res 23: 635–644PubMedCrossRefGoogle Scholar
  23. Pardridge WM, Triguero D, Yang J, Cancilla PA (1990) Comparison of in vitro and in vivo models of drug transcytosis through the blood brain barrier. J Pharmacol Exp Ther 253: 884–891PubMedGoogle Scholar
  24. Pardridge WM, Golden PL, Kang YS, Bickel U (1997) Brain microvascular and astrocyte localization of P-glycoprotein. J Neurochem 68: 1278–1285PubMedCrossRefGoogle Scholar
  25. Paulson OB, Knudson GM, Moos T (1999) Alfred Benson Symposium 45, Brain Barrier Systems, Munksgaard, KopenhagenGoogle Scholar
  26. Reese TS, Karnovsky MJ (1967) Fine structural localisation of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34: 207–217PubMedCrossRefGoogle Scholar
  27. Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F (1998) Mrpl multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71: 705–715Google Scholar
  28. Rist RJ, Romero IA, Chan MW, Couraud PO, Roux F (1997) Abbott NJ. F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors. Brain Res 768: 10–18PubMedCrossRefGoogle Scholar
  29. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P (1995) Absence of the mdr-la p-glycoprotein in mice affects tissue distribution and pharmacokinietics of dexamethason, digoxin, and cyclosporin A. J Clin Invest 96: 1698–1705PubMedCrossRefGoogle Scholar
  30. Schinkel AH, Smit JJ, van Tellingen 0, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, to Riele HP, et al (1994) Disruption of the mouse mdr-1 p-glycoprotein gene leads to a deficiency in the blood brain barrier and to increased sensitivity to drugs. Cell 77: 491–502PubMedCrossRefGoogle Scholar
  31. Schinkel AH, Wagenaar E, Mol CA, van Deemter L (1996) P-glycoprotein in the blood brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 2517–2524PubMedCrossRefGoogle Scholar
  32. Schlosshauer B (1993) The blood-brain barrier: morphology, molecules, and neurothelin. Bioessays 15: 341–346PubMedCrossRefGoogle Scholar
  33. Seelig A (1998a) A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251: 252–61PubMedCrossRefGoogle Scholar
  34. Seelig A. (1998b) How does P-glycoprotein recognize its substrates? Int J Clin Pharm Ther 36: 50–4Google Scholar
  35. Smith QR (2000) Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 130: 10165–10225Google Scholar
  36. Sobue K, Yamamoto N, Yoneda K, Hodgson ME, Yamashiro K, Tsuruoka N, Tsuda T, Katsuya H, Miura Y, Asai K, Kato T (1999) Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res 35: 155–164PubMedCrossRefGoogle Scholar
  37. Tsuji A (1998) p-Glycoprotein-mediated efflux of anticancer drugs at the blood-brain barrier. Ther Drug Monit 20:588–590Google Scholar
  38. Wiijsman JA, Shivers RR (1998) Immortalized mouse brain endothelial cells are ultrastructurally similar to endothelial cells and respond to astrocyteconditioned medium. In Vitro Cell Develop Biol Anim 34.777–784Google Scholar
  39. Williams SK, Gillis JF, Matthews MA, Wagner RC, Bitensky MW (1980) Isolation and characterization of brain endothelial cells: morphology and enzyme activity. J Neurochem 35: 374–381PubMedCrossRefGoogle Scholar
  40. Zhang Y, Han H, Elmquist WF, Miller DW (2000) Expression of various multidrug resistance-associated protein ( Mrp) homologues in brain microvessel endothelial cells. Brain Res 87: 148–53Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • G. Fricker

There are no affiliations available

Personalised recommendations